imidazole has been researched along with Chronic Hepatitis C in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " SOF-based therapy was well-tolerated, and no serious adverse events were reported." | 1.51 | Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study. ( Chen, B; Chen, EQ; Jiang, W; Tang, H; Tao, YC; Wang, ML; Wang, YH; Wu, DB, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, DB | 1 |
| Jiang, W | 1 |
| Wang, YH | 1 |
| Chen, B | 1 |
| Wang, ML | 1 |
| Tao, YC | 1 |
| Chen, EQ | 1 |
| Tang, H | 1 |
1 other study available for imidazole and Chronic Hepatitis C
| Article | Year |
|---|---|
Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study.
Topics: Adult; Aged; Antiviral Agents; Carbamates; China; Drug Therapy, Combination; Female; Genotype; Hepac | 2019 |